US 9833468
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
granted A61KA61K31/713A61K47/6455
Quick answer
US patent 9833468 (Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 51
- CPC classes
- A61K, A61K31/713, A61K47/6455, A61P, A61P43/00